Sisram Medical Ltd (HKG:1696)
Hong Kong · Delayed Price · Currency is HKD 4.090
-0.110 (-2.62%)
Feb 11, 2026, 4:08 PM HKT
Sisram Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 20.6 | 25.13 | 31.5 | 40.17 | 31.25 | 13.34 |
Depreciation & Amortization | 17.36 | 17.31 | 14.24 | 12.4 | 12.29 | 10.46 |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | -0.02 | - | - | - |
Asset Writedown & Restructuring Costs | 0.1 | 0.1 | - | - | - | - |
Loss (Gain) From Sale of Investments | -4.15 | -4.15 | - | - | - | - |
Loss (Gain) on Equity Investments | -0.03 | -0.03 | 0.42 | 0.52 | 0.31 | - |
Stock-Based Compensation | -0.79 | -0.79 | 0.49 | 3.17 | 0.29 | - |
Provision & Write-off of Bad Debts | 2.2 | 2.2 | 1.14 | 0.56 | 1.4 | 1.45 |
Other Operating Activities | -1.34 | 3.04 | 3.06 | 6.46 | 8.74 | 3.84 |
Change in Accounts Receivable | -13.93 | -13.93 | -3.79 | -16.24 | -23.36 | -2.04 |
Change in Inventory | -4.55 | -4.55 | -4.08 | -19.36 | -19.44 | -5.57 |
Change in Accounts Payable | 5.7 | 5.7 | -5.47 | 0.83 | 0.89 | -2.55 |
Change in Unearned Revenue | 0.23 | 0.23 | 1.78 | 0.07 | 5.75 | 2.23 |
Change in Other Net Operating Assets | 2.85 | 2.85 | 4.68 | -6.54 | 14.27 | 4.56 |
Operating Cash Flow | 24.23 | 33.08 | 43.94 | 22.04 | 32.38 | 25.74 |
Operating Cash Flow Growth | -39.25% | -24.70% | 99.36% | -31.93% | 25.80% | 22.34% |
Capital Expenditures | -3.41 | -2.75 | -8.57 | -4.75 | -2.97 | -9.27 |
Sale of Property, Plant & Equipment | -0.05 | 0.01 | 0.01 | 0.04 | - | 0.18 |
Cash Acquisitions | -1.76 | -1.76 | -32.22 | - | -43.27 | - |
Sale (Purchase) of Intangibles | -15.24 | -15.4 | - | -59.57 | - | - |
Investment in Securities | 2.24 | 12.16 | -3.31 | 15.96 | 3.88 | -25.17 |
Other Investing Activities | 0.59 | 1.14 | 11.09 | -3.79 | -4.42 | 0.76 |
Investing Cash Flow | -17.65 | -6.6 | -33 | -52.11 | -46.77 | -33.51 |
Short-Term Debt Issued | - | 7.55 | 4.44 | 5.89 | 3.08 | - |
Long-Term Debt Issued | - | - | - | - | - | 0.1 |
Total Debt Issued | 23.38 | 7.55 | 4.44 | 5.89 | 3.08 | 0.1 |
Short-Term Debt Repaid | - | -7.11 | -5.68 | -6.97 | -5.18 | - |
Long-Term Debt Repaid | - | -7.2 | -5.97 | -4.98 | -4.63 | -5.28 |
Total Debt Repaid | -31.46 | -14.31 | -11.65 | -11.96 | -9.81 | -5.28 |
Net Debt Issued (Repaid) | -8.08 | -6.76 | -7.21 | -6.06 | -6.74 | -5.19 |
Issuance of Common Stock | - | - | - | - | 79.18 | - |
Common Dividends Paid | -9.45 | -9.45 | -10.51 | -9.33 | -4.19 | -6.27 |
Other Financing Activities | -1.26 | 0.09 | -3.24 | -2.46 | -12.47 | -0.75 |
Financing Cash Flow | -18.79 | -16.12 | -20.97 | -17.85 | 55.78 | -12.21 |
Foreign Exchange Rate Adjustments | 2.2 | -0.81 | -4.23 | -2.21 | 0.16 | 3.62 |
Net Cash Flow | -10.01 | 9.57 | -14.26 | -50.13 | 41.55 | -16.36 |
Free Cash Flow | 20.82 | 30.33 | 35.37 | 17.29 | 29.41 | 16.46 |
Free Cash Flow Growth | -37.44% | -14.23% | 104.62% | -41.23% | 78.66% | -7.85% |
Free Cash Flow Margin | 6.02% | 8.69% | 9.84% | 4.88% | 9.99% | 10.16% |
Free Cash Flow Per Share | 0.04 | 0.07 | 0.08 | 0.04 | 0.07 | 0.04 |
Cash Interest Paid | 0.28 | 0.25 | 0.49 | 0.43 | 0.39 | 0.43 |
Cash Income Tax Paid | 3.97 | 7.44 | 7.89 | 8.41 | 7.54 | 1.47 |
Levered Free Cash Flow | 8.11 | 32.29 | 9.27 | -42.56 | 4.23 | 27.56 |
Unlevered Free Cash Flow | 9.8 | 33.83 | 10.56 | -41.48 | 5.48 | 28.23 |
Change in Working Capital | -9.71 | -9.71 | -6.89 | -41.24 | -21.89 | -3.37 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.